Dr. Reddy's Laboratories
RDY
#1699
Rank
A$17.86 B
Marketcap
A$21.36
Share price
0.35%
Change (1 day)
-5.58%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$3.04 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are A$3.04 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31A$2.92 B48.71%
2024-03-31A$1.96 B18.94%
2023-03-31A$1.65 B-8.2%
2022-03-31A$1.79 B8.19%
2021-03-31A$1.66 B-0.51%
2020-03-31A$1.67 B-3.15%
2019-03-31A$1.72 B-12.94%
2018-03-31A$1.98 B2.63%
2017-03-31A$1.93 B23.72%
2016-03-31A$1.56 B-11.28%
2015-03-31A$1.75 B23.17%
2014-03-31A$1.42 B16.05%
2013-03-31A$1.23 B4.73%
2012-03-31A$1.17 B10.14%
2011-03-31A$1.06 B17.1%
2010-03-31A$0.91 B-22.89%
2009-03-31A$1.18 B13.93%
2008-03-31A$1.03 B-18.58%
2007-03-31A$1.27 B-13.53%
2006-03-31A$1.47 B493.95%
2005-03-31A$0.24 B44.94%
2004-03-31A$0.17 B15.58%
2003-03-31A$0.14 B9.99%
2002-03-31A$0.13 B-54.04%
2001-03-31A$0.29 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$174.08 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.08 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$92.26 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$94.14 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$99.40 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France